MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Anti-diabetic Drug Use and the Risk of Parkinson’s Disease among Older Adults in Japan: the LIFE Study

    Y. Kimura, S. Ge, T. Kitamura, L. Zha, Y. Shimomura, M. Komatsu, Y. Gon, S. Komukai, M. Maeda, K. Kiyohara, H. Mochizuki, H. Fukuda (Suita, Japan)

    Objective: This study aims to assess the potential association between specific antidiabetic drug use and the risk of PD in Japan’s super-aging society. Background: Emerging…
  • 2025 International Congress

    Epidemiology of Parkinson’s disease in Southern Brazil: Age- and Sex-Specific Findings from the PROBE-PD Study

    G. Pereira, N. Soares, C. Sangali, D. Teixeira-Dos-Santos, G. Valença, B. Lopes, P. Brandão, C. Rieder, A. Schuh (Porto Alegre, Brazil)

    Objective: To examine the prevalence of Parkinson’s disease and parkinsonism in individuals aged 60 years and older in a population-based sample from Southern Brazil, analyzing…
  • 2025 International Congress

    Educational Strategies for Enhancing Caregiver Knowledge and Capacities in Parkinson’s Disease Management: A Comprehensive Review

    S. A. Hassan, S. Abozeid, Y. M.HUSSEINY, H. Abdelbar, S. Elrobeigi, M. M. Elsayed (Giza, Egypt)

    Objective: To evaluate the effectiveness of educational strategies in enhancing caregiver knowledge, skills, and confidence in managing Parkinson’s disease (PD) and to identify gaps in…
  • 2025 International Congress

    Trends in U.S. Drug Use Among Hospitalized Parkinson’s Patients Experiencing Delirium

    H. Kamo, R. Burke, T. Mehta, M. Remz, M. Okun, C. Hess (Gainesvile, USA)

    Objective: To examine drug use trends among hospitalized Parkinson’s disease (PD) patients in the U.S. and to assess the association between PD medications and delirium.…
  • 2025 International Congress

    Force Estimation as a Method to Assess Proprioception in Parkinson’s Disease Patients

    M. Wilken, G. Bianchi, M. Martínez Sucre, C. Cruz Molina, G. Noel, D. Andres, M. Merello (Buenos Aires, Argentina)

    Objective: To evaluate the validity of force estimation as a method for assessing proprioception, and to determine if proprioception is impaired in Parkinson's disease (PD)…
  • 2025 International Congress

    Analysis of statistical data on patients with Parkinson’s disease.

    R. Matmurodov, S. Jumanazarova, E. Abduqodirov, M. Abdullayeva (Tashkent, Uzbekistan)

    Objective: To determine the spread of the disease by sex and age groups among the population of Uzbekistan. Background: Parkinson's disease is quite relevant throughout…
  • 2025 International Congress

    Evaluating the Efficacy of Home-Based Exercise Interventions for Individuals with Mild to Moderate Parkinson’s Disease: A Systematic Review

    M. M. Elsayed, M. Alomari, N. Abdeltawab, O. Hafez, N. Elmestkawy, M. Mustafa, A. Abdelsalhin, S. A. Hassan (Mansoura, Egypt)

    Objective: To systematically evaluate the effectiveness of HBEI on motor symptoms, balance, and overall well-being in individuals with mild to moderate PD, providing insights into…
  • 2025 International Congress

    Alpha-Synuclein Accumulation-Attenuating Effect of Brain-Derived Neurotrophic Factor in Primary Cell Culture Model of Parkinson’s Disease

    I. Hlushchuk, MT. Airavaara (Helsinki, Finland)

    Objective: To explore the role of neurotrophic signaling pathways in modulating the effect of brain-derived neurotrophic factor (BDNF) on pre-formed fibrils (PFFs)- induced alpha-synuclein (aSyn)…
  • 2025 International Congress

    Glial interaction with Parkinsonian disorders biomarkers: alpha-synuclein, dopaminergic dysfunction and clinical stages

    L. Souza, D. Teixeira, G. Pereira, E. Zimmer, W. Borelli, A. Schuh (Porto Alegre, Brazil)

    Objective: We aim to investigated the relationship between glial markers and Parkinson's disease. Background: Neuronal α-Synuclein Disease (NSD) has recently been proposed as a framework for…
  • 2025 International Congress

    Improving Motor and Non-motor Symptoms in Parkinson’s Disease: A combined Pharmaceutical and Digital Approach Targeting Parallel Neural Circuits

    A. Amedi, N. Saporta, T. Tamir, R. Sivan Hoffmann, M. Catalogna (Herzliya, Israel)

    Objective: We aimed to demonstrate the parallel neural mechanisms underlying the effects of combining standard levodopa treatment with the DopApp digital intervention on motor and…
  • « Previous Page
  • 1
  • …
  • 39
  • 40
  • 41
  • 42
  • 43
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley